SAN DIEGO, April 20, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a royalty management company, today announced the completion of its spin-off of First Tracks Biotherapeutics, Inc., its former biopharma operations business.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
